Through the generous support of The Eli and Edythe Broad Foundation, we are pleased to announce a new research initiative supporting a Path to Public Funding. This may include NIH, CIRM, DOD and other organizations providing significant multi-year support for research in any area of regenerative medicine. While proposals from individual PIs will be considered, collaborative proposals between PIs are strongly encouraged. The proposed research should be distinguishable from currently funded research in the PI’s laboratory. Applications are encouraged across departments and schools at USC and CHLA, and may include faculty at the California Institute of Technology as co-PIs. Partnerships with and between junior faculty are strongly encouraged.
The successful teams will receive $125,000 of direct support for one year, renewable through a no cost extension for a second year. We anticipate funding up to four projects. Funding may cover co-PI salaries (up to 10%), supplies and minor equipment (up to $5,000). PIs with greater than $500,000 of discretionary funds are not eligible to receive direct funding, but are eligible to apply as co-PIs.
A brief letter of intent (LOI) to apply must be submitted by 5 p.m. PST on October 28, 2022. The LOI should include a one-page project summary emphasizing the significance of the research, the target for funding (eg., NIH R01, NIH Heal Initiative, CIRM DISC0), and the key target data to be acquired with funding to enable a competitive submission. A one-page biosketch should indicate PI’s past and present funding and key publications in relevant area. If multiple PIs, highlight synergistic advantage of the partnership.
Applicants solicited for a full proposal will be notified by November 7, 2022. Full proposals will be due by 5 p.m. PST on December 16, 2022. Instructions for full proposal submission will be provided shortly. Successful applicants will be notified in early 2023 with the expectation that funding commence by March 1, 2023.
Enquiries and LOI submissions should be directed to Dr. Juliane Glaeser, Program Director for the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC (Juliane.Glaeser@med.usc.edu).